# Mesalazine

## Asacol 500mg suppository

##### 臨採

| TAH Drug Code      | [EASA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EASA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of mildly to moderately active ulcerative proctitis, colitis, or proctosigmoiditis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | 1-2 suppository TID, after a bowel movement. The dose depends on the response.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | Patients with known or suspected hypersensitivity to salicylates or aminosalicylates or to any ingredients in the suppository vehicle. Severe renal impairment: eGFR<30mL/min/1.73m2. Severe liver impairment. Age <2 years.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | Common Dermatologic: Rash (Up to 6% ; pediatrics, 5% ) Gastrointestinal: Abdominal pain (Adult, 2.2% to 18% ; pediatrics 5% or more ), Burping (16% ), Diarrhea (Adults, up to 8% ; pediatrics, 5% ), Nausea (Up to 4% ), Vomiting (Less than 1% to 5% ; pediatric, 5% or more ) Musculoskeletal: Arthralgia (Less than 3% to greater than 5% ) Neurologic: Asthenia (Less than 1% to greater than 5% ), Headache (Adults, 2.9% to 14% ; pediatrics, 5% or more ) Respiratory: Nasopharyngitis (Adults, 1.4% to 4% ; pediatrics, 15% ), Rhinitis (5% or more ) Other: Pain (Up to 14% ) Serious Cardiovascular: Myocarditis, Pericarditis Dermatologic: Generalized exanthematous pustulosis, acute, Stevens-Johnson syndrome, Toxic epidermal necrolysis Gastrointestinal: Exacerbation of ulcerative colitis (Pediatrics, 12% ), Gastrointestinal hemorrhage (2% or greater ), Pancreatitis (Less than 1% ), Rectal hemorrhage (Less than 3% to 2% or greater.) Hematologic: Agranulocytosis, Aplastic anemia, Leukopenia, Neutropenia, Pancytopenia, Thrombocytopenia (Less than 1% ) Hepatic: Cholestatic hepatitis (Less than 3% ), Hepatotoxicity, Liver failure, Sclerosing cholangitis Immunologic: Anaphylaxis, Angioedema, Drug reaction with eosinophilia and systemic symptoms, Edema of face (Less than 1% ), Hypersensitivity reaction Renal: Renal impairment Other: Infectious disease, Intolerance to drug, Syndrome |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/mesalamine-mesalazine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

## Colasa enema 4gm/100mL

| TAH Drug Code      | [ECOL4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ECOL4)                                                                                                                                            |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ulcerative colitis, mild to moderate proctitis and proctosigmoiditis.                                                                                                                                             |
| Dosing             | Adults: 2gm-4gm once at night. Children: Dose is not determined.                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                          |
| Contraindications  | Hypersensitivity to mesalazine or any component in the preparation. History of hypersensitivity to salicylate preparations. Severe liver impairment. Severe renal impairment (GFR less than 30 ml/minute/1.73m2). |
| Adverse Effects    | Nausea, diarrhea, abdominal pain, headache.                                                                                                                                                                       |
| Pregnancy          | Compatible                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/mesalamine-mesalazine-drug-information)                                                                                                                              |

## MezaVant XL 1200mg prolonged release

| TAH Drug Code      | [OMEZA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMEZA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | The induction of remission and maintenance of remission in mild to moderate active ulcerative colitis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | 2.4 to 4.8g (2 to 4 tablets) QD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Patients who are allergic to acetylsalicylic acid, other salicylates (including mesalazine), or any components in "MezaVant." Patients with severe renal insufficiency (glomerular filtration rate <30 mL/min/1.73 m2) and/or liver impairment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Adverse Effects    | >10%: Gastrointestinal: Abdominal pain (1% to 21%), constipation (?11%), eructation (?26%) Nervous system: Headache (3% to 14%) Respiratory: Nasopharyngitis (children and adolescents: 15%; adults: 1% to 4%) 1% to 10%: Cardiovascular: Hypertension (?1%) Dermatologic: Acne vulgaris (?1%), alopecia (<3%), pruritus (?1%), skin rash (?6%) Endocrine & metabolic: Increased serum triglycerides (<3%), weight loss (children and adolescents: 2%) Gastrointestinal: Abdominal distention (1%), anorectal pain (rectal: 1%; includes discomfort and pain on insertion of enema tip), bloody diarrhea (children and adolescents: 2%), diarrhea (2% to 8%), dyspepsia (?4%), flatulence (?6%), gastroenteritis (?2%), gastrointestinal hemorrhage, hemorrhoids (?1%), lower abdominal pain (<3%), nausea (?4%), pancreatitis (?2%), rectal pain (rectal: 1% to 2%), sclerosing cholangitis (children and adolescents: 2%), tenesmus (?2%), upper abdominal pain (1% to 5%), vomiting Genitourinary: Hematuria (<3%), urinary frequency Hematologic & oncologic: Decreased hematocrit (<3%), decreased hemoglobin (<3%), rectal hemorrhage (<3%) Hepatic: Cholestatic hepatitis (<3%) Infection: Infection (?2%), influenza (1% to 5%) viral infection (children and adolescents: ?2%; including adenovirus) Nervous system: Dizziness (?9%), fatigue (<3%), nervousness (?2%), pain (<3%), paresthesia (?2%), vertigo (<3%) Neuromuscular & skeletal: Arthralgia (<3%), arthropathy (?2%), back pain (?6%), lower extremity pain (rectal: ?2%) Ophthalmic: Visual disturbance (?2%) Otic: Tinnitus (<3%) Renal: Decreased creatinine clearance (<3%) Respiratory: Cough (children & adolescents: 5%; adults: ?1%), dyspnea (<3%), flu-like symptoms (4%), rhinitis (8%), sinusitis (children and adolescents: 7%), upper respiratory tract infection (children and adolescents: ?5%) Miscellaneous: Fever (?3%), intolerance syndrome (2% to 3%; 7% to 14% in literature) (Mizuno 2020; Shimizu 2017) <1%: Cardiovascular: Edema, facial edema, hypotension, palpitations, pericarditis (Brown 2016), tachycardia, vasodilation Dermatologic: Diaphoresis, ecchymoses, eczema, erythema nodosum, lichen planus, nail disease, prurigo, skin photosensitivity, urticaria, xeroderma Endocrine & metabolic: Albuminuria, amenorrhea, heavy menstrual bleeding, increased amylase, increased gamma-glutamyl transferase, increased lactate dehydrogenase, increased thirst, Kawasaki-like syndrome (Waanders 1992) Gastrointestinal: Abnormal stools, anorexia, duodenal ulcer, dysphagia, esophageal ulcer, fecal incontinence, increased serum lipase, oral candidiasis, oral mucosa ulcer, rectal polyp, rectal tenesmus Genitourinary: Hypomenorrhea, mastalgia, uterine hemorrhage Hematologic & oncologic: Thrombocythemia, thrombocytopenia Hepatic: Increased serum alanine aminotransferase, increased serum alkaline phosphatase, increased serum aspartate aminotransferase Nervous system: Depression, drowsiness, insomnia, malaise Neuromuscular & skeletal: Asthenia, lower limb cramp, myalgia, tremor Ophthalmic: Conjunctivitis Otic: Otalgia Respiratory: Pharyngolaryngeal pain, pulmonary infiltrates Postmarketing: Immunologic: Drug reaction with eosinophilia and systemic symptoms (Lim 1994) |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/mesalamine-mesalazine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

